Collum L M, Benedict-Smith A, Hillary I B
Br J Ophthalmol. 1980 Oct;64(10):766-9. doi: 10.1136/bjo.64.10.766.
The results of a randomised double-blind clinical trial of 3% acyclovir and 0.5% idoxuridine (IDU) ophthalmic ointments in 60 patients with corneal dendritic ulceration are presented. Ulcers in all 30 patients treated with acyclovir healed compared with 22 (76%) of 29 patients treated with IDU (P < 0.01). Patients treated with acyclovir healed more rapidly (average 4.4 days) than those who received IDU (average 9.2 days) (P < 0.01). No serious side effects were observed, though transient stinging was recorded in 8 patients receiving acyclovir and in 2 patients receiving IDU. Other side effects in the IDU treated group were watering in 2 patients and superficial punctate erosions in 6 patients.
本文介绍了一项针对60例角膜树枝状溃疡患者的随机双盲临床试验结果,该试验比较了3%阿昔洛韦眼膏和0.5%碘苷(IDU)眼膏的疗效。接受阿昔洛韦治疗的30例患者的溃疡均愈合,而接受IDU治疗的29例患者中有22例(76%)愈合(P<0.01)。接受阿昔洛韦治疗的患者愈合速度更快(平均4.4天),快于接受IDU治疗的患者(平均9.2天)(P<0.01)。未观察到严重副作用,不过8例接受阿昔洛韦治疗的患者和2例接受IDU治疗的患者记录有短暂刺痛。IDU治疗组的其他副作用包括2例患者流泪,6例患者出现浅层点状糜烂。